BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19013118)

  • 1. [Bisphosphonate-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review].
    Jotterand V; Moll S; Martin PY; Saudan P
    Nephrol Ther; 2009 Apr; 5(2):134-8. PubMed ID: 19013118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient.
    Kunin M; Kopolovic J; Avigdor A; Holtzman EJ
    Nephrol Dial Transplant; 2004 Mar; 19(3):723-6. PubMed ID: 14767032
    [No Abstract]   [Full Text] [Related]  

  • 3. Podocyte injury associated glomerulopathies induced by pamidronate.
    Barri YM; Munshi NC; Sukumalchantra S; Abulezz SR; Bonsib SM; Wallach J; Walker PD
    Kidney Int; 2004 Feb; 65(2):634-41. PubMed ID: 14717935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.
    Markowitz GS; Appel GB; Fine PL; Fenves AZ; Loon NR; Jagannath S; Kuhn JA; Dratch AD; D'Agati VD
    J Am Soc Nephrol; 2001 Jun; 12(6):1164-1172. PubMed ID: 11373339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of collapsing focal segmental glomerulosclerosis following chemotherapy for myeloma.
    Shah S; Cavenagh J; Sheaf M; Thuraisingham RC
    Am J Kidney Dis; 2004 Feb; 43(2):e10-2. PubMed ID: 14750118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pamidronate-induced kidney injury in a patient with metastatic breast cancer.
    Nagahama M; Sica DA
    Am J Med Sci; 2009 Sep; 338(3):225-8. PubMed ID: 19581797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells.
    Dijkman HB; Weening JJ; Smeets B; Verrijp KC; van Kuppevelt TH; Assmann KK; Steenbergen EJ; Wetzels JF
    Kidney Int; 2006 Jul; 70(2):338-44. PubMed ID: 16761013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Idiopathic collapsing glomerulopathy in children: report of two cases].
    Wei RG; Chen SM; Jiang T; Jiang XY; Zeng Y; Mo Y
    Zhonghua Er Ke Za Zhi; 2004 Oct; 42(10):731-3. PubMed ID: 16221337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate.
    Pascual J; Torrealba J; Myers J; Tome S; Samaniego M; Musat A; Djamali A
    Osteoporos Int; 2007 Oct; 18(10):1435-8. PubMed ID: 17404782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature.
    Jia N; Cormack FC; Xie B; Shiue Z; Najafian B; Gralow JR
    BMC Cancer; 2015 Jul; 15():535. PubMed ID: 26197890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate nephrotoxicity.
    Perazella MA; Markowitz GS
    Kidney Int; 2008 Dec; 74(11):1385-93. PubMed ID: 18685574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma.
    Desikan R; Veksler Y; Raza S; Stokes B; Sabir T; Li ZJ; Jagannath S
    Br J Haematol; 2002 Nov; 119(2):496-9. PubMed ID: 12406092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Collapsing glomerulopathy: a new entity associated with nephrotic syndrome and end-stage renal failure].
    Avila-Casado MC
    Rev Invest Clin; 1999; 51(6):367-73. PubMed ID: 10972063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of collapsing focal segmental glomerulosclerosis.
    Raja R; Nada R; Yadav AK; Kumar A; Goyal A; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
    Ren Fail; 2016 Jul; 38(6):894-8. PubMed ID: 27266801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerulonephritis as a Type of Kidney Injury in Multiple Myeloma: a Report of 2 Cases.
    Vakili Sadeghi M; Akbari R
    Iran J Kidney Dis; 2017 May; 11(3):249-252. PubMed ID: 28575887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy of pamidronate in reducing skeletal associated events in patients with advanced multiple myeloma].
    Adamietz IA
    Strahlenther Onkol; 1997 Jan; 173(1):52-3. PubMed ID: 9082587
    [No Abstract]   [Full Text] [Related]  

  • 17. [Collapsing glomerulopathy].
    Said JC; Letelier LM; González A; Escobillana C; Pisano R
    Rev Med Chil; 2012 Oct; 140(10):1342-6. PubMed ID: 23559294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate nephropathy: A case series and review of the literature.
    de Roij van Zuijdewijn C; van Dorp W; Florquin S; Roelofs J; Verburgh K
    Br J Clin Pharmacol; 2021 Sep; 87(9):3485-3491. PubMed ID: 33595131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular focal segmental glomerulosclerosis: Clinical and pathologic features.
    Stokes MB; Valeri AM; Markowitz GS; D'Agati VD
    Kidney Int; 2006 Nov; 70(10):1783-92. PubMed ID: 17021605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual Cause and Presentation of Collapsing Focal Segmental Glomerulosclerosis.
    Bhat ZY; Sharma N; Pillai U; Singh A
    Am J Ther; 2016; 23(3):e957-60. PubMed ID: 25420079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.